Oncology and Hematology

Nicole Shonka, M.D.

Academic office:                                                                                         
UNMC Oncology/Hematology Division
987680 Nebraska Medical Center
Omaha, NE 68198-7680

Main practice location:
Peggy D. Cowdery Patient Care Center
Lied Transplant Center
987835 Nebraska Medical Center
Omaha, NE 68198-7835
Ph. 402-559-3848
Fax. 402-559-6520

Cancer Center at Village Pointe
111 North 175th Street
Omaha, NE 68118
Ph. 402-596-3100

University of Nebraska Medical Center, Resident, (2002-2005)
University of Nebraska Medical Center, Fellow, (2007-2009)
University of Texas MD Anderson Cancer Center, Fellow (2009-2010)

Hospital Appointments:
The Nebraska Medical Center University Hospital

Research in novel therapies for primary tumors of the brain and spine, secondary brain tumors, and leptomeningeal disease

Biographical Sketch:
Dr. Shonka is an Assistant Professor in the Oncology/Hematology Division in the Department of Internal Medicine at UNMC. Dr. Shonka received her medical education at UNMC and did her residency and general oncology fellowship at UNMC as well. She then went to the University of Texas' MD Anderson Cancer Center where she completed an additional Neuro-oncology fellowship and returned to Nebraska as faculty in July 2010. She is currently the only fellowship-trained Neuro-oncologist in the state of Nebraska. She currently serves on the editorial board for Targeted Oncology, is an expert reviewer for the Journal of Neuro-Oncology, and is a member of the national Disease-Focused Expert Panel on Brain Tumors for the Veterans' Administration Medical Center.

Select Publications:

Shonka NA. Targeted Therapy for Ependymoma, Targeted Oncology, In press, June 2011

Shonka N, Hsu S, Yung A. Tumors of the Central Nervous System. M.D. Anderson Oncology. 2011

Shonka N, Groves M. Advanced Therapy of Breast Disease. 3rd ed. B. C. Decker; 2011. Management of Central Nervous System Metastases in Breast Cancer

Shonka N, de Groot J.. Cancer Management: A Multidisciplinary Approach. 13th ed. UBM Medica; 2011. Primary and Metastatic Brain Tumors

Shonka N, de Groot J, Gilbert M, Yung A, Piao Y, Liu J, Bekele N, Wen P, Chen A, Heymach J. Changes in IL-6, IL-10, and IL-13 predict toxicity from aflibercept in patients with recurrent glioblastoma. Neuro Oncol 2010;12(suppl 4):39.

Shonka N, Yung A, Bekele N, Gilbert M. Outcomes for patients with anaplastic astrocytoma treated with primary chemoradiation versus single modality or sequential treatment. Neuro Oncol 2010;12(suppl 4):42.

Tsung A, Prahbu S, Lei X, Bekele N, Shonka N. Cerebellar Glioblastoma: A retrospective review of 21 patients at a single institution. Neuro Oncol 2010;12(suppl 4): 54.

Shonka N, de Groot J, Gilbert M, Yung A, Piao Y, Liu J, Bekele N, Wen P, Chen A, Heymach J. Correlating cytokine levels with toxicity in the treatment of glioblastoma with aflibercept in NABTC 0601. Proc Am Soc Clin Oncol 2010 (e12507)